# Setara Biosciences funding rounds and investors

As of 30 Oct 2026, Setara Biosciences has raised $90M across 1 verified round on record; latest: $90 million Series A, announced 30 Oct 2026.

A clinical-stage rare disease biotech formed by Actio Biosciences alums

Page: https://fireround.dev/companies/setara-biosciences

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-30 | Series A | $90 million | not stated | Canaan Partners, Deerfield Management, Droia, EcoR1 Capital, Euclidean Capital, Jazz Pharmaceuticals, Regeneron Ventures | [businesswire.com](https://www.businesswire.com/news/home/20261030022827/en/Setara-Biosciences-Announces-%2490-Million-Series-A-Financing-to-Advance-Precision-Medicines-for-Rare-Genetic-Diseases-and-Related-Expansion-Indications), [amp.axios.com](https://amp.axios.com/setara-biosciences-raises-90m-43945a43-0dc3-41a9-8ee6-5d8a3160f50d.html), [axios.com](https://www.axios.com/pro/biotech-deals/2026/10/30/setara-biosciences-raises-90m) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.